Primary Biliary Cholangitis - 11 Studies Found
| RECRUITING |
: IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA) : Primary Biliary Cholangitis : 2024-12-03 : Seladelpar 10 mg one capsule daily for up to 52 weeks |